Compile Data Set for Download or QSAR
Report error Found 153 Enz. Inhib. hit(s) with all data for entry = 11812
TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649721BDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50: 100nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649750BDBM649750(2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(py...)
Affinity DataIC50: 140nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649705BDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50: 200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649763BDBM649763(8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (p...)
Affinity DataIC50: 200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649697BDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50: 200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649748BDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50: 260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649747BDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50: 260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649759BDBM649759(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649710BDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50: 300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649704BDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50: 400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649711BDBM649711(3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phen...)
Affinity DataIC50: 400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649723BDBM649723(5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)t...)
Affinity DataIC50: 400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649747BDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50: 400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649710BDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50: 400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649749BDBM649749((E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)m...)
Affinity DataIC50: 410nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649762BDBM649762(8-fluoro-4-hydroxy-3-methyl- 6-(3-(4-(pyrrolidin-1...)
Affinity DataIC50: 430nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649751BDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649757BDBM649757(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649721BDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649721BDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649697BDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649756BDBM649756(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649695BDBM649695(3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thi...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649748BDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50: 500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649751BDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649747BDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649760BDBM649760(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649705BDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649705BDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649758BDBM649758(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649710BDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649719BDBM649719(3-fluoro-5-formyl-4-hydroxy- N-(5-(4- (trifluorome...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649761BDBM649761(2-(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phe...)
Affinity DataIC50: 600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649722BDBM649722(2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phen...)
Affinity DataIC50: 700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649723BDBM649723(5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)t...)
Affinity DataIC50: 700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649704BDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50: 700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649722BDBM649722(2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phen...)
Affinity DataIC50: 800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649763BDBM649763(8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (p...)
Affinity DataIC50: 800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649724BDBM649724(3-fluoro-2-hydroxy-5-(3-(6- (pyrrolidin-1-yl)pyrid...)
Affinity DataIC50: 800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649757BDBM649757(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649697BDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649711BDBM649711(3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phen...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649749BDBM649749((E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)m...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649708BDBM649708(3-fluoro-5-formyl-4-hydroxy- N-(2-phenyloxazol-4- ...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649703BDBM649703(N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylth...)
Affinity DataIC50: 900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649706BDBM649706(3-fluoro-5-formyl-4-hydroxy- N-(5-(4-(pyrrolidin-1...)
Affinity DataIC50: 1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 6(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649750BDBM649750(2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(py...)
Affinity DataIC50: 1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 9(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649703BDBM649703(N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylth...)
Affinity DataIC50: 1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649704BDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50: 1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

TargetToll-like receptor 2(Human)
Neuropore Therapies

US Patent
LigandChemical structure of BindingDB Monomer ID 649719BDBM649719(3-fluoro-5-formyl-4-hydroxy- N-(5-(4- (trifluorome...)
Affinity DataIC50: 1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Displayed 1 to 50 (of 153 total ) | Next | Last >>
Jump to: